Table 3.
Mortality after diagnosis of CSDH stratified by sex, age, treatment group, and prevalence of comorbidity. Also shown the mortality of the reference group
| Total sample n = 1133 | Men n = 736 | Women n = 397 | Age group 18–59 years n = 167 | Age group 60–79 years n = 565 | Age group ≥ 80 years n = 401 | Operative n = 965 | Non-operative n = 168 | Non-operative n = 161* | No comorbidity n = 206 | Reference group n = 4532 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative mortality | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % |
| 30 days | 38 | 3.4 | 26 | 3.5 | 12 | 3.0 | 3 | 1.8 | 15 | 2.7 | 20 | 5.0 | 25 | 2.6 | 13 | 7.7 | 8 | 5.0 | 3 | 1.5 | 16 | 0.4 |
| 90 days | 75 | 6.6 | 51 | 6.9 | 24 | 6.0 | 3 | 1.8 | 34 | 6.0 | 38 | 9.5 | 54 | 5.6 | 21 | 12.5 | 15 | 9.3 | 4 | 1.9 | 61 | 1.3 |
| 6 months | 108 | 9.5 | 74 | 10.1 | 34 | 8.6 | 5 | 3.0 | 45 | 8.0 | 58 | 14.4 | 82 | 8.5 | 26 | 15.5 | 20 | 12.4 | 6 | 2.9 | 125 | 2.8 |
| 1 year | 155 | 13.7 | 107 | 14.5 | 48 | 12.1 | 8 | 4.8 | 59 | 10.4 | 88 | 22.0 | 120 | 12.4 | 35 | 20.8 | 29 | 18.0 | 6 | 2.9 | 248 | 5.5 |
| 2 year | 254 | 22.4 | 168 | 22.8 | 86 | 21.7 | 20 | 12.0 | 97 | 17.1 | 137 | 34.2 | 200 | 20.7 | 54 | 32.1 | 47 | 29.2 | 19 | 9.2 | 486 | 10.7 |
*The patients (n = 7) who were not offered surgery (because presenting in a moribund state) were not included